PT Kalbe Farma Tbk : Kalbe Group Continues to Consider Growth Initiatives
January 25, 2021 at 10:50 am
Share
Kalbe Group Continues to Consider Growth Initiatives
The impact of COVID-19 pandemic has brought about unprecedented challenges to the lives of Indonesian people. As a company in the health sector, PT Kalbe Farma Tbk ('Kalbe') is compelled to contribute to the health and well-being of Indonesians in various ways by participating in drug development, drug and vaccine distribution as well as continuing to provide health and nutritional products. Kalbe plans to continue to implement strategic initiatives to grow its business in the near and medium term. Such initiatives may include launching new health and nutritional products in light of increasing consumer health awareness resulting from the COVID-19 pandemic and continuing to implement alternative marketing strategies as a result of the pandemic and seeking potential fundraising options which may include capital market transactions by certain subsidiaries of Kalbe.
Kalbe and/or its relevant subsidiaries are still considering the initiatives mentioned and there is no certainty or assurance that such initiatives will be implemented. This information shall not be considered/deemed an invitation to purchase any securities of Kalbe or its subsidiaries.
--oOo--
Print
0Rate this article:
No rating
[Link]
Please login or register to post comments.
Attachments
Original document
Permalink
Disclaimer
PT Kalbe Farma Tbk published this content on 25 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 January 2021 10:49:01 UTC
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
PT KALBE FARMA TBK. 
